Up­dat­ed: FDA ap­proves an­ti-in­flam­ma­to­ry drug Lodoco to treat car­dio­vas­cu­lar dis­ease

The FDA green­light­ed on Tues­day an an­ti-in­flam­ma­to­ry drug de­signed to re­duce the risks re­lat­ed to car­dio­vas­cu­lar dis­ease.

Agepha Phar­ma, a Dubai-based phar­ma, se­cured the ap­proval …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER